Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
It has been proposed that damage caused by ROS and RNS including HNE causes impaired glucose metabolism and electrochemical gradients across membranes which in turn affects calcium homeostasis (Butterfield and Halliwell 2019)
It is designed to be administered once weekly via a subcutaneous injection, and its primary purpose is the treatment of obesity and overweight
The only legitimate way to access these medicines in the UK is through participation in a registered clinical trial, which can be found via NIHR Be Part of Research or ClinicalTrials.gov
Description SLU-PP-332 Peptide SLU-PP-332 is a synthetic compound investigated for its activity as a REV-ERB/ agonist , Chemical Makeup Molecular Formula: C30H35N5O3 Molecular Weight: 513.63 g/mol Mechanism of Action: REV-ERB/ receptor agonist Solubility: DMSO, ethanol Structure Type: Non-peptidic small molecule Research Use Only SLU-PP-332 is provided for in vitro and in vivo laboratory research use only
Which membrane systems act as the initiating sites of lipid peroxidation in distinct contexts, and how do organelle contact sites shape the propagation or containment of ferroptotic signals
You will receive a confirmation email with all the necessary information
US$ 20.09
US$ 26.01
US$ 27.00
US$ 27.74
US$ 26.21
US$ 27.39
US$ 25.92
